NK cells lyse T regulatory cells that expand in response to an intracellular pathogen

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1729-1736

  Roy, Sugata ^a   Barnes, Peter F ^a,b   Garg, Ankita ^a   Wu, Shiping ^a   Cosman, David ^c   Vankayalapati, Ramakrishna ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b Health Science Center   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD16 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSCRIPTION FACTOR FOXP3; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; MEMBRANE PROTEIN; MONOKINE; NATURAL KILLER CELL ACTIVATING RECEPTORS; SIGNAL PEPTIDE; ULBP1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTRACELLULAR BACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ISOLATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; CYTOTOXICITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY;

ANTIGENS, CD4; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FORKHEAD TRANSCRIPTION FACTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MONOKINES; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY;

EID: 40749162020     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1729     Document Type: Article

References (52)

1. Gazit, R., R. Gruda, M. Elboim, T. I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, E. Greenbaum, et al. 2006. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7: 517-523.
2. Yokoyama, W. M., S. Kim, and A. R. French. 2004. The dynamic life of natural killer cells. Annu. Rev. Immunol. 22: 405-429.
3. Vankayalapati, R., B. Wizel, S. E. Weis, H. Safi, D. L. Lakey, O. Mandelboim, B. Samten, A. Porgador, and P. F. Barnes. 2002. The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 168: 3451-3457.
4. Artavanis-Tsakonas, K., and E. M. Riley. 2002. Innate immune response to malaria: rapid induction of IFN-γ from human NK cells by live Plasmodium falciparum-infected erythrocytes. J. Immunol. 169: 2956-2963.
5. Draghi, M., A. Pashine, B. Sanjanwala, K. Gendzekhadze, C. Cantoni, D. Cosman, A. Moretta, N. M. Valiante, and P. Parham. 2007. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J. Immunol. 178: 2688-2698.
6. Cooper, M. A., T. A. Fehniger, A. Fuchs, M. Colonna, and M. A. Caligiuri. 2004. NK cell and DC interactions. Trends Immunol. 25: 47-52.
7. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333.
8. Gregory, S. H., X. Jiang, and E. J. Wing. 1996. Lymphokine-activated killer cells lyse Listeria-infected hepatocytes and produce elevated quantities of interferon-γ. J. Infect. Dis. 174: 1073-1079.
9. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182: 1045-1056.
10. Vankayalapati, R., A. Garg, A. Porgador, D. E. Griffith, P. Klucar, H. Safi, W. M. Girard, D. Cosman, T. Spies, and P. F. Barnes. 2005. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 175: 4611-4617.
11. + T cell effector function in response to an intracellular pathogen. J. Immunol. 172: 130-137.
12. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
13. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
14. Rouse, B. T., and S. Suvas. 2004. Regulatory cells and infectious agents: detentes cordiale and contraire. J. Immunol. 173: 2211-2215.
15. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
16. + regulatory T cell proliferation. J. Exp. Med. 202: 919-929.
17. Wolf, A. M., D. Wolf, M. Steurer, G. Gastl, E. Gunsilius, and B. Grubeck-Loebenstein. 2003. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res. 9: 606-612.
18. + T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J. Immunol. 176: 1582-1587.
19. + regulatory T cells. Proc. Natl. Acad. Sci. USA 103: 5460-5465.
20. Wizel, B., M. Palmieri, C. Mendoza, B. Arana, J. Sidney, A. Sette, and R. Tarleton. 1998. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J. Clin. Invest. 102: 1062-1071.
21. 2 dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur. J. Immunol. In press.
22. + regulatory T cells. Trends Immunol. 27: 541-544.
23. + regulatory T cells express lower levels of the IL-7 receptor α chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods 319: 41-52.
24. + T reg cells. J. Exp. Med. 203: 1701-1711.
25. Lanier, L. L. 2001. On guard-activating NK cell receptors. Nat. Immunol. 2: 23-27.
26. Cosman, D., J. Mullberg, C. L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N. J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14: 123-133.
27. Salgame, P. 2005. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr. Opin. Immunol. 17: 374-380.
28. Foulds, K. E., C. Y. Wu, and R. A. Seder. 2006. Th1 memory: implications for vaccine development. Immunol. Rev. 211: 58-66.
29. Kursar, M., M. Koch, H. W. Mittrucker, G. Nouailles, K. Bonhagen, T. Kamradt, and S. H. Kaufmann. 2007. Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol. 178: 2661-2665.
30. Guyot-Revol, V., J. A. Innes, S. Hackforth, T. Hinks, and A. Lalvani. 2006. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am. J. Respir. Crit. Care Med. 173: 803-810.
31. + T cells. J. Immunol. 169: 3232-3241.
32. + TR cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197: 111-119.
33. + CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect. Immun. 71: 1755-1762.
34. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23: 287-296.
35. + regulatory T cells. Nat. Med. 10: 29-30.
36. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200: 331-343.
37. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78: 2454-2459.
38. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062-1071.
39. + T cells in regulation of the immune response during human tuberculosis. Clin. Exp. Immunol. 144: 25-34.
40. + T regulatory cell activity following infection. J. Immunol. 177: 4670-4678.
41. + T cells in patients with HTLV-I-associated neuroimmunological disease. J. Clin. Invest. 115: 1361-1368.
42. hi T-regulatory cells. Blood 108: 253-261.
43. + Treg development and function during allergic airway inflammation in vivo. J. Clin. Invest. 115: 313-325.
44. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
45. Feng, C. G., M. Kaviratne, A. G. Rothfuchs, A. Cheever, S. Hieny, H. A. Young, T. A. Wynn, and A. Sher. 2006. NK cell-derived IFN-γ differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J. Immunol. 177: 7086-7093.
46. Cerwenka, A., and L. L. Lanier. 2001. Ligands for natural killer cell receptors: redundancy or specificity. Immunol. Rev. 181: 158-169.
47. Borchers, M. T., N. L. Harris, S. C. Wesselkamper, M. Vitucci, and D. Cosman. 2006. NKG2D ligands are expressed on stressed human airway epithelial cells. Am. J. Physiol. 291: L222-L231.
48. Gasser, S., S. Orsulic, E. J. Brown, and D. H. Raulet. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190.
49. Rabinovich, B. A., J. Li, J. Shannon, R. Hurren, J. Chalupny, D. Cosman, and R. G. Miller. 2003. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 170: 3572-3576.
50. Zheng, Y., S. Z. Josefowicz, A. Kas, T. T. Chu, M. A. Gavin, and A. Y. Rudensky. 2007. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445: 936-940.
51. Marson, A., K. Kretschmer, G. M. Frampton, E. S. Jacobsen, J. K. Polansky, K. D. MacIsaac, S. S. Levine, E. Fraenkel, H. von Boehmer, and R. A. Young. 2007. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931-935.
52. + T cells via OX40-OX40 ligand interactions. J. Immunol. 173: 3716-3724.